BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 12709926)

  • 1. Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
    Mac Gillavry MR; Prins MH
    Semin Thromb Hemost; 2003 Apr; 29(2):219-26. PubMed ID: 12709926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
    Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
    Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilia and venous thromboembolism.
    Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is screening for thrombophilia cost-effective?
    Wu O; Greer IA
    Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
    Waselenko JK; Nace MC; Alving B
    Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
    Saadatnia M; Tajmirriahi M
    Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings.
    Margaglione M; Brancaccio V; Ciampa A; Papa ML; Grandone E; Di Minno G
    Haematologica; 2001 Jun; 86(6):634-9. PubMed ID: 11418373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon.
    Böhm G; Al-Khaffaf H
    Int Angiol; 2003 Jun; 22(2):116-24. PubMed ID: 12865876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
    Eichinger S
    Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
    Martinelli I; Taioli E; Battaglioli T; Podda GM; Passamonti SM; Pedotti P; Mannucci PM
    Arch Intern Med; 2003 Dec 8-22; 163(22):2771-4. PubMed ID: 14662632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
    Bauersachs R; Kuhl H; Lindhoff-Last E; Ehrly AM
    Vasa; 1996; 25(3):209-20. PubMed ID: 8967151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications.
    De Stefano V; Rossi E; Leone G
    Semin Vasc Med; 2003 Feb; 3(1):47-60. PubMed ID: 15199492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium.
    Nelson SM; Greer IA
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.